BCYC · Bicycle Therapeutics Plc ADR
United States · RS rating 29 · As of 2026-11-03
| Price | 3.67 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 38 / 51 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 6 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +65.9% |
| Sales growth Q/Q | +308.7% |
| Distance from 52-week high | +51.2% |
| Market cap (USD) | $338.6M |